Eva Henry
Wichita, KSNPI 1801810312
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $92,113 of the $100,705 with a category attached, or 91.5%. AbbVie accounts for 95.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $25,657 and has fallen 62.0% since, to $9,741 in 2025.
Across 495 payments — averaging $203.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$96K
- Medtronic$2K
- Abbott$596
- Pfizer$557
- Teva Pharmaceuticals USA, Inc.$439
- Amgen$222
- plus $937 from 10 others
What the payments were for
- Speaking & faculty fees$92,11391%
- Travel & lodging$2,2432%
- Food & beverage$5,9036%
- Education$4470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 323 | $96,311 |
| Medtronic | 26 | $1,644 |
| Abbott | 9 | $596 |
| Pfizer | 19 | $557 |
| Teva Pharmaceuticals USA, Inc. | 63 | $439 |
| Amgen(2 entities) | 8 | $222 |
| Avanir Pharmaceuticals, Inc. | 12 | $192 |
| Novartis | 9 | $155 |
| Biohaven Pharmaceuticals, Inc. | 11 | $148 |
| Axsome Therapeutics, Inc. | 2 | $127 |
| Lundbeck LLC | 2 | $120 |
| Biogen | 6 | $107 |
| Inspire Medical Systems, Inc. | 2 | $27 |
| Tanabe Pharma America, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$80,115
- QULIPTA$33,037
- INTELLIS ADAPTIVESTIM$772
- INFINITY$348
- NURTEC ODT$121
- INCEPTIV$108
- ZAVZPRET$103
- Symbravo$102
- VYEPTI$101
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydromorphone ErHydromorphone Hcl | 12 | $9,247 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $584 |
| ProgesteroneProgesterone, Micronized | 15 | $442 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $2 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.